Literature DB >> 25749627

Penile pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma with a novel pattern of SERPINE1-FOSB fusion detected by RT-PCR--report of a case.

Yoshi-Hiro Ide1, Yoshitane Tsukamoto2, Takaaki Ito3, Takahiro Watanabe1, Noboru Nakagawa3, Takashi Haneda3, Makoto Nagai3, Kiyofumi Yamanishi3, Seiichi Hirota1.   

Abstract

We experienced a rare case of penile mesenchymal tumor in a 43-year-old Japanese man. At least three nodules were observed around the penis. The tumors were composed of spindle- to oval-shaped atypical cells with and without prominent nucleoli. These cells were like myogenic cells, but negative for myogenic markers. They were positive for endothelial markers, such as ERG, Fli1 and CD31. They were also positive for nuclear and cytoplasmic FOSB which are not expressed in epithelioid hemangioendothelioma or epithelioid sarcoma. These pathological and immunohistochemical findings strongly suggested pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma (PHE/ES-HE). Since a recent report directly proved that two cases of PHE/ES-HE have SERPINE1-FOSB fusion gene by reverse transcription-polymerase chain reaction (RT-PCR), we examined whether the fusion gene is present or not in the present case by RT-PCR using fresh frozen surgical material. Sequencing of the PCR product revealed that this case has SERPINE1-FOSB fusion. The fusion pattern of our case was different from those of two previously reported cases. In our case, 86 nucleotides of SERPINE1 intron 1 were inserted between SERPINE1 exon 1 and the middle portion of FOSB exon 1, and a putative translation start codon was identified in SERPINE1 intron 1. Thus, this is the third case of PHE/ES-HE with SERPINE1-FOSB fusion proved by RT-PCR.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  FOSB immunohistochemistry; Penis; Pseudomyogenic hemangioendothelioma; SERPINE1-FOSB fusion

Mesh:

Substances:

Year:  2015        PMID: 25749627     DOI: 10.1016/j.prp.2015.02.003

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  6 in total

1.  The clinicopathological spectrum of pseudomyogenic hemangioendothelioma: report of an additional series with review of the literature.

Authors:  Yuefang Sun; Ming Zhao; I Weng Lao; Lin Yu; Jian Wang
Journal:  Virchows Arch       Date:  2020-01-24       Impact factor: 4.064

Review 2.  Update on selected advances in the immunohistochemical and molecular genetic analysis of soft tissue tumors.

Authors:  Khin Thway; Andrew L Folpe
Journal:  Virchows Arch       Date:  2019-11-07       Impact factor: 4.064

3.  Pseudomyogenic hemangioendothelioma: A misleading vascular tumor.

Authors:  Farah Sassi; Ghada Sahraoui; Lamia Charfi; Olfa Jaidane; Karima Mrad; Raoudha Doghri
Journal:  Int J Surg Case Rep       Date:  2022-09-12

4.  Expanding the Spectrum of Genetic Alterations in Pseudomyogenic Hemangioendothelioma With Recurrent Novel ACTB-FOSB Gene Fusions.

Authors:  Narasimhan P Agaram; Lei Zhang; Paolo Cotzia; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2018-12       Impact factor: 6.394

5.  Pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma of the lower limb: report of a rare case.

Authors:  Chuifeng Fan; Lianhe Yang; Xuyong Lin; Enhua Wang
Journal:  Diagn Pathol       Date:  2015-08-28       Impact factor: 2.644

6.  Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.

Authors:  Shintaro Sugita; Hiroshi Hirano; Noriaki Kikuchi; Terufumi Kubo; Hiroko Asanuma; Tomoyuki Aoyama; Makoto Emori; Tadashi Hasegawa
Journal:  Diagn Pathol       Date:  2016-08-11       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.